United States

People: Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

17 Feb 2017
Change (% chg)

$-0.03 (-3.27%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Jones, Robert 

Mr. Robert B. Jones is President and Chief Executive Officer, Director of the company. He has been our President and Chief Executive Officer since July 7, 2011. From April 2011 through July 6, 2011, Mr. Jones was our Interim President and Chief Executive Officer. Mr. Jones was our Senior Vice President and Chief Operating Officer from April 2008 to April 2011. From May, 2003 to March, 2008, Mr. Jones served first as the Vice President, Finance and then as Vice President, Strategy and Business Analysis of Adolor Corporation. From November 2000 to May 2003 he served as Vice President, Finance and then as Chief Operating Officer of Opt-E-Script, Inc., a privately held personalized medicine company where Mr. Jones was responsible for all commercialization activities. Prior to that, Mr. Jones was Vice President, Sales and Marketing for Purepac Pharmaceutical Company. Mr. Jones received his M.B.A. from the University of North Carolina and a B.S. from Cornell University. Mr. Jones was appointed a director of the Company in July 2011.

Basic Compensation

Total Annual Compensation, USD 387,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 116,424
Fiscal Year Total, USD 503,424

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Jones


Peter Clemens


Robert Seiser


J. Bradley Rivet


Albert Brzeczko


James Emigh

As Of  30 Dec 2014